Related Experiment Video
Updated: May 3, 2026
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Risk and benefit of statins in stroke secondary prevention
1Department of Neurology, CHU Mont-Godinne, Institute of Neurosciences, Avenue Therasse 1, B- 5530 Yvoir, Belgium. patrice.laloux@uclouvain.be.
Insights
Statins effectively reduce recurrent stroke risk in secondary prevention, though they may increase brain hemorrhage risk. Intensive statin therapy shows greater benefit without increased side effects.
Area of Science:
- Neurology
- Cardiology
- Pharmacology
Background:
- Statins are recommended for secondary stroke prevention to reduce cardiovascular events.
- Debate exists regarding statin benefits in specific stroke patient groups and the risk of cerebral hemorrhage.
Purpose of the Study:
- To review the efficacy and safety of statins in secondary stroke prevention.
- To assess statin benefits across different demographics and stroke subtypes.
Main Methods:
- Systematic review of studies on statin use in stroke patients.
- Analysis of outcomes including recurrent stroke and cerebral hemorrhage.
Main Results:
- Statins significantly decrease the risk of further strokes.
- An increased risk of brain hemorrhage was observed.
- Benefits were noted in both men and women, older patients, and those with carotid artery stenosis.
- Intensive statin therapy (LDL-cholesterol < 1.8 mmol/L) appears more effective than less intensive treatment.
Conclusions:
- Statins are effective in reducing secondary stroke risk but carry a risk of cerebral hemorrhage.
- Intensive statin therapy may offer superior benefits.
- Further research is needed for small vessel disease and patient selection to mitigate hemorrhage risk.
Abstract:
Statin is now recommended in secondary prevention after stroke or transient ischemic attacks to reduce the risk of a new stroke or major cardiovascular events. However, some issues about the extent of the benefit in some stroke patients and the risk of cerebral hemorrhage remain debated. This review shows that statins are significantly effective in decreasing the risk of further strokes despite an increase in the risk of brain hemorrhage. A significant benefit was observed in men and women, in aged patients and possibly to a greater extent in patients with carotid artery stenosis. Intensive statin therapy lowering the LDL-cholesterol beyond the cut-off value of 1.8 mmol/L (70 mg/dl) seems to be more effective than less intensive treatment and without an increased risk of side effects. Overall, statins are well tolerated. Further prospective studies should clarify whether the effect is of the same magnitude in small vessel disease and how to select the patients to reduce the risk of cerebral hemorrhage.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
01:26Atherosclerosis III: Management
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
01:26Coronary Artery Disease IV: Preventive Measures